Point-of-care, 64mT MRI performs as well as conventional CT and MRI while improving patient safety.
Using a portable, low-field MRI system to assess patients in the intensive care unit (ICU) for brain injury works equally as well as traditional imaging measures, a new study as revealed.
By using a 64 mT MRI that can plug into a standard electrical outlet in any room, a team of researchers from Yale New Haven Hospital successfully detected neuroimaging findings present in patients who were both positive for COVID-19 and infection free. The patients, said the team led by Kevin Sheth, M.D., division chief of neurocritical care and emergency neurology, experienced no complications or adverse effects from the point-of-care system.
The team published their findings Tuesday in JAMA Neurology.
“These findings demonstrate for the first time – to our knowledge – the deployment of a portable MRI to the bedside of patients with critical illness,” they wrote. “In acute neurological settings, it is well established that non-invasive, time-sensitive neuroimaging is the cornerstone of triage and treatment pathways.”
Traditional MRI that requires patient transport can jeopardize patient safety due to the magnetic fields, as well as potentially compromise monitoring equipment, endanger venous access, and risk endotracheal tube displacement. A portable, bedside system eliminates those challenges, the team said.
Related Content: MRI Room Service: Portable Machine Brings In-Room Scans to Stroke Patients
Alongside these safety advantages, the team also set out to see whether the portable system could effectively pinpoint neurological abnormalities. To conduct this assessment, they performed point-of-care, low-field exams on 50 patients – 34 men and 16 women – who were admitted to either the neurological ICU or COVID-19 ICU at Yale New Haven Hospital between Oct. 30, 2019, and May 20, 2020. These patients had neurological injury or alterations and no contraindications for conventional MRI.
Hyperfine Portable MRI
According to Sheth's team, 20 patients were diagnosed with COVID-19 via the RT-PCR test, and the rest had ischemic stroke (9 patients), hemorrhagic stroke (12 patients), subarachnoid hemorrhage (2 patients), traumatic brain injury (3 patients), and brain tumor (4 patients). All patients underwent 64 mT scans with the Hyperfine point-of-care system. Of the group, 37 underwent T1-weighted MRI, 48 had T2-weighted MRI, 45 underwent fluid-attenuated inversion recovery (FLAIR), and 32 had diffusion-weighted imaging. All scans were conducted an average of five days after ICU admission.
In addition, a number of patients also received conventional imaging. Of the 30 patients who were infection free, 6 had CT and 23 had MRI. Of the 20 COVID-19 patients, 8 had CT, and 3 had MRI.
Based on the team’s analysis of all the scans, the portable MRI system detected neurological finding in 29 out of 30 infection-free patients (97 percent). These findings also corresponded to the performance of conventional imaging except for one patient for whom the portable scan did not identify a diffuse subarachnoid hemorrhage. The portable system performed equally as well with COVID-19 patients, pinpointing neurological findings in 8 of 20 patients (40 percent), including intracranial hemorrhage, cerebral infarction, diffuse cerebral edema, and leukoencephalopathy. These results were in agreement with the conventional imaging tests.
“This single-center series of patients with critical illness in an intensive care setting demonstrated the feasibility of low-field, portable MRI,” the team said. “These findings demonstrate the potential role of portable MRI to obtain neuroimaging in complex clinical care settings.”
While the results do point to the ability of the system to function in a variety of care environments, Sheth's team still concluded that additional multi-center research is needed to assess brain pathology at fixed points.
“This approach may hold promise for portable assessment of neurological injury in other scenarios,” they said, “including the emergency department, mobile stroke units, and resource-limited environments.”
AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses on CT
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.